Education
About Us
Working with TipRanks
Follow Us
Eastwood Bio-Medical Canada Inc (TSE:EBM)
:EBM
Total Valuation
Eastwood Bio-Medical Canada has a market cap or net worth of C$50.98M. The enterprise value is C$29.67M.
Market CapC$50.98M
Enterprise ValueC$29.67M
Share Statistics
Eastwood Bio-Medical Canada has 68,885,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding68,885,970
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Eastwood Bio-Medical Canada’s return on equity (ROE) is 0.35 and return on invested capital (ROIC) is 35.96%.
Return on Equity (ROE)0.35
Return on Assets (ROA)-1.66
Return on Invested Capital (ROIC)35.96%
Return on Capital Employed (ROCE)0.34
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover2.56
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Eastwood Bio-Medical Canada is ―. Eastwood Bio-Medical Canada’s PEG ratio is 9.00.
PE Ratio―
PS Ratio96.16
PB Ratio-52.06
Price to Fair Value-52.06
Price to FCF-4.44K
Price to Operating Cash Flow-3.90K
PEG Ratio9.00
Income Statement
In the last 12 months, Eastwood Bio-Medical Canada had revenue of 702.08K and earned -455.87K in profits. Earnings per share was -0.01.
Revenue702.08K
Gross Profit454.39K
Operating Income-437.70K
Pretax Income-455.87K
Net Income-455.87K
EBITDA-342.05K
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was 21.05K and capital expenditures -4.00, giving a free cash flow of 21.04K billion.
Operating Cash Flow21.05K
Free Cash Flow21.04K
Free Cash Flow per Share<0.01
Dividends & Yields
Eastwood Bio-Medical Canada pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.86
52-Week Price Change2.78%
50-Day Moving Average0.79
200-Day Moving Average0.51
Relative Strength Index (RSI)38.51
Average Volume (3m)3.49K
Important Dates
Eastwood Bio-Medical Canada upcoming earnings date is Mar 2, 2026, TBA (Confirmed).
Last Earnings DateSep 25, 2025
Next Earnings DateMar 2, 2026
Ex-Dividend Date―
Financial Position
Eastwood Bio-Medical Canada as a current ratio of 0.03, with Debt / Equity ratio of -7.37%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap<0.01
Net Debt to EBITDA-0.23
Interest Coverage Ratio-69.63
Taxes
In the past 12 months, Eastwood Bio-Medical Canada has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Eastwood Bio-Medical Canada EV to EBITDA ratio is -197.60, with an EV/FCF ratio of -4.44K.
EV to Sales96.27
EV to EBITDA-197.60
EV to Free Cash Flow-4.44K
EV to Operating Cash Flow-4.44K
Balance Sheet
Eastwood Bio-Medical Canada has C$22.03K in cash and marketable securities with C$71.33K in debt, giving a net cash position of -C$49.30K billion.
Cash & Marketable SecuritiesC$22.03K
Total DebtC$71.33K
Net Cash-C$49.30K
Net Cash Per Share>-C$0.01
Tangible Book Value Per Share-C$0.02
Margins
Gross margin is 63.18%, with operating margin of -62.34%, and net profit margin of -64.93%.
Gross Margin63.18%
Operating Margin-62.34%
Pretax Margin-64.93%
Net Profit Margin-64.93%
EBITDA Margin-48.72%
EBIT Margin-64.04%
Analyst Forecast
The average price target for Eastwood Bio-Medical Canada is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-9.02%
EPS Growth Forecast14.29%